Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Depreciation & Amortization (CF) (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Depreciation & Amortization (CF) readings, the most recent being $82000.0 for Q4 2023.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 8.89% to $82000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $296000.0, a 21.28% decrease, with the full-year FY2025 number at $200000.0, down 33.33% from a year prior.
  • Depreciation & Amortization (CF) hit $82000.0 in Q4 2023 for Elicio Therapeutics, down from $104000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $154000.0 in Q2 2022 to a low of $6000.0 in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 4 years was $47000.0 (2020), compared with a mean of $59400.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 77.78% in 2021 and later soared 569.57% in 2022.
  • Elicio Therapeutics' Depreciation & Amortization (CF) stood at $14000.0 in 2020, then surged by 128.57% to $32000.0 in 2021, then skyrocketed by 181.25% to $90000.0 in 2022, then decreased by 8.89% to $82000.0 in 2023.
  • The last three reported values for Depreciation & Amortization (CF) were $82000.0 (Q4 2023), $104000.0 (Q2 2023), and $110000.0 (Q1 2023) per Business Quant data.